NetworkNewsBreaks Archive - Page 2068 of 2081

FridayOct 28, 2016 1:33 pm

Opexa Therapeutics’ (OPXA) Tcelna Misses Endpoints in MS Study, Shares Plunge

Shares of Opexa Therapeutics (NASDAQ: OPXA) sank 68% in morning trade on news the biopharmaceutical company’s phase 2b Abili-T clinical trial to evaluate the efficacy and safety of Tcelna® (imilecleucel-T) in patients with secondary progressive multiple sclerosis (SPMS) failed to meet primary endpoint of reduction in brain volume change (atrophy), nor did it meet the secondary endpoint of reduction of the rate of sustained disease progression. The drug candidate did show a favorable safety and tolerability profile. To view the full press release, visit: http://nnw.fm/eHA99 About Opexa Therapeutics Opexa Therapeutics is a biopharmaceutical company developing personalized immunotherapies based on ImmPath®,…

ThursdayOct 27, 2016 2:03 pm

Cheribum Interests, Inc. (CHIT): BudCube Cultivation Advances Technology Deployment, Shares Climb

Shares Cherubim Interests (OTC: CHIT) are up 8% mid-day, potentially moving from yesterday’s news that its wholly owned subsidiary, BudCube Cultivation Systems USA, has initiated due diligence for its inaugural site location to deploy its BudCube Cultivation Systems Technology. BudCube Cultivation Systems is an expansion-stage alternative construction and real estate development company and developer of a proprietary, fully portable and scalable, Controlled Environment Agriculture Technology that serves as a turnkey solution for cultivators of legal medical and recreational cannabis. "This industry is moving very rapidly … The market is there, the demand is high, but the supply from legal cultivators…

ThursdayOct 27, 2016 2:01 pm

GrowLife, Inc. (PHOT) Board Extends CEO Employment, Shares Retreat from Morning Spike

GrowLife (OTC: PHOT) shares slipped from an early morning spike following news that the company has extended CEO Marco Hegyi’s employment contract for another two years. “Marco Hegyi has led PHOT back to active trading from the Gray Sheet market, effectively maintained positive and constructive relationships with shareholders, customers and suppliers, and enabled PHOT to continue operating through the Company’s most challenging times,” GrowLife Compensation Committee chairman and board member Michael Fasci stated in the news release. “Therefore, with this employment agreement, GrowLife will maintain management continuity for the next two years under Marco’s leadership.” To view the press release,…

ThursdayOct 27, 2016 1:58 pm

Provision Holding, Inc. (PVHO) Posts Higher Revs, Widened Loss for FY2016, Shares Up

Provision Holding (OTCQB: PVHO) is trading higher in mid-day trade after the 3D holographic display technologies provider posted full-year revenues of $5.0 million compared to $575,000 for the prior year ended June 30, 2016. The company attributes the increase to sales and installations of its 3D Savings Center kiosks in retail stores. Installation expenses widened the company’s net loss to $6.2 million, compared to a net loss of $0.8 million for the same period last year. Gross profit for the period was $526,000, nearly double gross profit of $265,000 in the previous year. To view the full press release, visit: http://nnw.fm/HWc1P…

ThursdayOct 27, 2016 1:57 pm

Inventory Increase Pushes EXOlifestyle, Inc. (EXOL) Shares Higher

Shares of EXOlifestyle (OTCQB: EXOL) climbed 9% in mid-day trade on news of the company’s inventory expansion. The developer of innovative and healthy brands within the health and wellness industry this morning announced that to meet rising demand of its products, it has ordered additional inventory with a retail value of $400,000. To view the full press release, visit: http://nnw.fm/X3yBD About EXOlifestyle Inc. EXOlifestyle Inc. is a management firm which develops and operates innovative and healthy brands within the health & wellness industry with a strong focus on athletic apparel. EXO is a functional sports apparel brand, and designer and producer of active wear products…

ThursdayOct 27, 2016 12:26 pm

Harris & Harris Group, Inc. (TINY): Mersana’s Oncology Drug Candidate Cleared by FDA

Harris & Harris Group (NASDAQ: TINY) focuses on investments in transformative life science companies. Among the company’s portfolio of such investments is Mersana Therapeutics, Inc., whose Investigational New Drug (IND) application was recently cleared by the FDA, enabling the start of phase 1 clinical trials for its lead oncology drug candidate, XMT-1522. The compound is Mersana’s first pipeline product and defines a new class of HER2-targeted therapies. “XMT-1522 represents a promising therapeutic approach for cancer patients with significant unmet medical needs and we are pleased to be in a position to move this therapy into clinical development.” Donald A. Bergstrom,…

ThursdayOct 27, 2016 12:24 pm

3 Business Strategies Driving Moxian, Inc.’s (MOXC) Success in New Media Marketing

China-based Moxian (OTCQB: MOXC) provides some of the biggest interactive marketing products of the mobile Internet era. The competitive nature of the broader technology sector keeps the company on its toes, and company CEO James Tan keeps Moxian firing on all cylinders with a sharp focus on accurately identifying demand, prioritizing quality over quantity, and developing the infrastructure necessary to meet demand. “Over the years, the thriving new media market has given rise to a fast-growing net advertising sector in China and the rest of the world. In China alone, the advertising market is expected to hit around $80 billion…

WednesdayOct 26, 2016 1:49 pm

Cemtrex, Inc. (CETX) Preliminary FY2016 Results Drive Shares Higher

Shares of Cemtrex (NASDAQ: CETX) are 10% higher in mid-day trade after the industrial and manufacturing solutions company announced preliminary financial results for the fiscal year ended September 30, 2016. Cemtrex said it expects revenues in the range of $93 million to $95 million compared to revenues of $56 million in fiscal 2015; net income in the range of $4.8 million to $5.0 million compared to net income of $2.8 million in fiscal 2015; and EBITDA in the range of $6.6 million to $7.0 million compared to $3.9 million a year ago. EPS is expected to increase to $0.52 per…

WednesdayOct 26, 2016 1:48 pm

Tonix Pharmaceuticals Holding Corp. (TNXP) Prices $5.2M Public Offering, Shares Sharply Lower

Shares of Tonix Pharmaceuticals (NASDAQ: TNXP) are down 21% in mid-day trade. The company this morning announced the pricing of an underwritten public offering of common stock and warrants at an offering price of $0.55 per unit. The company said it plans to use the gross proceeds of approximately $5.2 million to support the continued development of TNX-102 SL for the treatment of posttraumatic stress disorder (PTSD), including completion of the first interim analysis in the phase 3 study in military-related PTSD, to further develop other pipeline programs, for working capital and other general corporate purposes. To view the press…

WednesdayOct 26, 2016 1:47 pm

Ritter Pharmaceuticals, Inc. (RTTR) Shares Higher on $5M Public Offering

Ritter Pharmaceuticals (NASDAQ: RTTR) is trading more than 10% higher mid-day after the company this morning priced an underwritten public offering of 2,127,660 shares of its common stock at a price to the public of $2.35 for gross proceeds of approximately $5 million. The offering is expected to close on October 31, 2016, subject to customary closing conditions. To view the press release, visit: http://nnw.fm/tyL4U About Ritter Pharmaceuticals, Inc. Ritter Pharmaceuticals, Inc. develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. The Company is advancing human gut health research by exploring the metabolic capacity of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks